RXDX
Point72 Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,465,420
| Closed | -$157M | – | 2319 |
|
|
2023
Q1 | $157M | Buy |
1,465,420
+199,337
| +16% | +$21.4M | 0.49% | 31 |
|
|
2022
Q4 | $139M | Buy |
1,266,083
+673,187
| +114% | +$74.1M | 0.47% | 29 |
|
|
2022
Q3 | $35M | Sell |
592,896
-773,530
| -57% | -$45.6M | 0.14% | 185 |
|
|
2022
Q2 | $38.6M | Buy |
1,366,426
+1,316,426
| +2,633% | +$37.2M | 0.16% | 167 |
|
|
2022
Q1 | $1.89M | Sell |
50,000
-84,537
| -63% | -$3.19M | 0.01% | 804 |
|
|
2021
Q4 | $5.32M | Sell |
134,537
-601,865
| -82% | -$23.8M | 0.02% | 612 |
|
|
2021
Q3 | $17.5M | Sell |
736,402
-27,700
| -4% | -$657K | 0.08% | 329 |
|
|
2021
Q2 | $18.8M | Sell |
764,102
-35,898
| -4% | -$882K | 0.08% | 282 |
|
|
2021
Q1 | $14.6M | Buy |
+800,000
| New | +$14.6M | 0.07% | 325 |
|